connAction Session
MD 12 - High-risk steatotic liver disease: new developments in non-invasive tests and treatment - recommendations for clinical practice and directions for the future
Lectures
1
Chairperson's introduction
02:00Valérie Vilgrain, Clichy / FR
2
The hepatologist's perspective
15:00Laurent Castera, Clichy / FR
3
Expert panel discussion
28:00Expert panel discussion
2 min
Chairperson's introduction
Valérie Vilgrain, Clichy / France
- To highlight new developments in the diagnosis and treatment of high-risk steatotic liver disease.
- To critically review recent evidence in imaging and put this in perspective with the new treatment developments.
- To provide recommendations for clinical practice and directions for the future.
15 min
The hepatologist's perspective
Laurent Castera, Clichy / France
15 min
The radiologist's perspective
Valérie Vilgrain, Clichy / France
28 min
Expert panel discussion